1. Home
  2. CCC vs CPRX Comparison

CCC vs CPRX Comparison

Compare CCC & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CCC Intelligent Solutions Holdings Inc.

CCC

CCC Intelligent Solutions Holdings Inc.

N/A

Current Price

$5.31

Market Cap

3.6B

Sector

Technology

ML Signal

N/A

Logo Catalyst Pharmaceuticals Inc.

CPRX

Catalyst Pharmaceuticals Inc.

HOLD

Current Price

$28.97

Market Cap

3.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCC
CPRX
Founded
1980
2002
Country
United States
United States
Employees
2185
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.6B
3.4B
IPO Year
N/A
2006

Fundamental Metrics

Financial Performance
Metric
CCC
CPRX
Price
$5.31
$28.97
Analyst Decision
Buy
Strong Buy
Analyst Count
8
1
Target Price
$8.94
$35.00
AVG Volume (30 Days)
11.6M
1.8M
Earning Date
04-30-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
28.24
EPS
N/A
1.68
Revenue
N/A
$119,072,803.00
Revenue This Year
$10.22
$9.20
Revenue Next Year
$8.58
$10.51
P/E Ratio
N/A
$17.18
Revenue Growth
N/A
16.39
52 Week Low
$4.58
$19.05
52 Week High
$8.68
$32.56

Technical Indicators

Market Signals
Indicator
CCC
CPRX
Relative Strength Index (RSI) 48.42 66.77
Support Level $4.86 $22.41
Resistance Level $6.34 $32.56
Average True Range (ATR) 0.29 1.19
MACD 0.02 0.19
Stochastic Oscillator 58.66 48.07

Price Performance

Historical Comparison
CCC
CPRX

About CCC CCC Intelligent Solutions Holdings Inc.

CCC Intelligent Solutions Holdings Inc is a provider of cloud, mobile, AI, telematics, hyperscale technologies, and applications for the property and casualty insurance economy. The company's SaaS platform connects trading partners, facilitates commerce, and supports mission-critical, AI-enabled digital workflows. It operates in a single segment being Domestic segment, which provides SAAS platform for the P&C insurance economy and derives revenues from providing customers with software subscriptions to the platform in addition to providing professional services and non-software services. The company has its presence in the United States and China. The majority of the revenue is generated from the United States.

About CPRX Catalyst Pharmaceuticals Inc.

Catalyst Pharmaceuticals Inc is a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing, and commercializing novel high-quality medicines for patients living with rare and difficult to treat diseases. The Company sells three commercial stage drug products, FIRDAPSE (amifampridine), AGAMREE (vamorolone), and FYCOMPA (perampanel). The Company is currently seeking to further expand its product portfolio, with a focus on acquiring the rights to immediately and near-term accretive assets to treat rare (orphan) diseases across therapeutic areas, including clinical-stage opportunities with established proof of concept.

Share on Social Networks: